Dr Robert Verkerk, Dr Parveen Bhatarah and Dr Ignazio Garaguso explore the future of CBD and other non-psychotropic cannabinoids and cannabimimetics.
List view / Grid view
Dr Parveen Bhatarah
The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.